Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake

(2017) Osamu Manabe et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis

(2017) Mitsutomi Ishiyama et al.   EJNMMI Research

Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease

(2017) Amjad M. Ahmed et al.   Abdominal Radiology

Focal fat deposition in the liver: diagnostic challenges on imaging

(2017) Jong Keon Jang et al.   Abdominal Radiology

Hepatic glucose utilisation in hepatic steatosis and obesity

(2016) G. Keramida et al.   BIOSCIENCE REPORTS

Quantifying [18F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction

(2015) Björn A. Blomberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis

(2015) Osamu Manabe et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Endocrine stress responses and risk of type 2 diabetes mellitus

(2015) Azaz Siddiqui et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations

(2014) Yoshio Ishida et al.   ANNALS OF NUCLEAR MEDICINE

Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis

(2014) Azadeh Ahmadian et al.   JOURNAL OF NUCLEAR CARDIOLOGY

A Semi-Automated Technique Determining the Liver Standardized Uptake Value Reference for Tumor Delineation in FDG PET-CT

(2014) Kenji Hirata et al.   PLoS One

Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment

(2013) Jessica L. Hwang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis

(2013) Lars C. Gormsen et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

(2013) Ron Blankstein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis

(2012) Rémy LM Mostard et al.   BMC Pulmonary Medicine

18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis

(2011) Hiroshi Ohira et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis

(2011) R.L.M. Mostard et al.   RESPIRATORY MEDICINE

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept

(2009) Gonca G. Bural et al.   MOLECULAR IMAGING AND BIOLOGY

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

(2008) S A Harrison et al.   GUT

Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus

(2008) Ronald Borra et al.   METABOLISM-CLINICAL AND EXPERIMENTAL